Narrative review· 2008

Pramlintide, the synthetic analogue of amylin

Hoogwerf BJ

Diabetes, Metabolic Syndrome and Obesity

PubMed: 18561511
Evidence level: moderate
Verification: verified

Summary

Review of pramlintide, a synthetic amylin analogue used with mealtime insulin in diabetes.

Limitations

Narrative review|Applies to licensed pramlintide rather than all amylin analogues|Adjunctive insulin context

Linked peptides

Amylin Analogue

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.